The factor XIa inhibitor reduced the rate of disabling/fatal strokes versus placebo, with a consistent net clinical benefit.

Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

HELSINKI, Finland—Patients with atrial fibrillation (AF) who have had an ischemic stroke continue to have a high risk of recurrent stroke even when they’re treated with oral anticoagulation, a ...

Age, comorbidities, disposition and wait times drove adherence to follow-up care for stroke across clinical models, according ...

AJMC®: In your experience, what are the most significant long-term clinical effects of a recurrent stroke? RUSSMAN: Recurrent strokes tend to have more severe long-term clinical effects than initial ...

Share on Pinterest Salt substitutes are a simple intervention that can help manage blood pressure and lower stroke risk. Maskot/Getty Images Salt substitutes may reduce stroke recurrence and death, ...

Surviving a stroke represents a significant health victory, but many survivors don’t realize they’ve entered a high-risk category for experiencing another event. Understanding why stroke lightning can ...

Large infarction in the middle cerebral artery (dark blue) New-onset dementia among stroke patients appears to be most prevalent after two or more strokes, indicating that providing the best possible ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...